Altre lingue ClouDr Group Limited

Azioni

9955

KYG2216H1011

Tempo differito Hong Kong S.E. Altri mercati azionari 03:20:49 09/05/2024			Variaz. 5gg	Var. 1 gen.
3,46 ^HKD	+1,76%		+11,97%	-49,49%

22/03	La perdita netta di ClouDr Group si riduce dell'81% nel 2023, mentre le entrate aumentano del 23,5%.	MT
21/03	ClouDr Group Limited riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services	15/04
ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%	22/03
ClouDr Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
ClouDr Launches Diabetes Tablets; Shares Up 3%	11/03
ClouDr Group Limited Announces Launch of Proprietary Product, Hetangjin Dapagliflozin Tablets	10/03
ClouDr Group Limited Enters into A Non-Legally Binding Strategic Cooperation Agreement with China Resources Kunming Shenghuo Pharmaceutical Co., Ltd	05/03
ClouDr Buys Back Shares	25/01
ClouDr Group Trustee Buys 1.3 Million Shares Under Award Scheme	18/01
ClouDr Unit to Get 200 Million Yuan Capital Injection	12/01
ClouDr Buys Back Shares for Incentive Scheme	11/01
ClouDr Group Applies to Register Diabetes Digital Therapeutics in China	03/01
ClouDr Group Limited Completes the Application for Registration as A Medical Device in the People's Republic of China in Respect of ClouDT-01	03/01
ClouDr Group to Buy Up to HK$80 Million of Shares	29/12
ClouDr Signs Marketing Deal With Shanxi Jinbo Bio Pharmaceutical	28/12
ClouDr Group Limited Enters into a Non-Legally Binding Strategic Cooperation Agreement with Shanxi Jinbo Bio-Pharmaceutical Co., Ltd	27/12
Cloudr Group Limited Announces Resignation of Liu Mengya as Joint Company Secretary	19/12
ClouDr Group Signs Digital Marketing Agreement with Pharmaceutical Company	30/11
ClouDr Says New Evidence Shows Ischelium Drug's Efficacy on Cognitive Improvement	16/11
ClouDr Group Limited Announces New Efficacy of Ischelium on Brain Covidative Fund Approval	16/11
ClouDr to be Added in MSCI China Small Cap Index	15/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ClouDr Group Limited

Azioni

9955

KYG2216H1011

Altre lingue

Filtri